Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease

By News Health
2 months Ago

(MedPage Today) — ORLANDO — Infusions of the investigational monoclonal antibody veligrotug improved symptoms among patients with active and chronic thyroid eye disease, the phase III THRIVE clinical program showed.
By week 15 in 113 patients…

Source link : https://www.medpagetoday.com/meetingcoverage/aace/115658

Author :

Publish date : 2025-05-19 19:34:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

When Systemic Therapy Is Delayed for Syphilitic Uveitis, Ceftazidime May Help

Monoclonal Antibodies May Stop Vertical HIV Transmission From Mom to Baby

Premature babies in UK to be immunised against winter virus RSV

FDA Advisors Give PTSD Drug Combination a Thumbs Down

Researchers Detail Alarming Rise in GI Cancers Among Young People

Surgery, Ablation Lead to Similar Outcomes for Small Liver Tumors